- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00267735
Measuring Preferences for Childbirth After Cesarean
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
As cesarean birth rates continue to climb, the number of women (currently about 420,000 annually) facing the decision of whether to have a repeat cesarean or to attempt a vaginal birth after cesarean (VBAC) will also increase. The objective of this proposed 18-month exploratory research study is to help pregnant women weigh risks and benefits in a childbirth decision using the Preferences Assessment Computer Module developed by the principal investigator. The long-term objective of the proposed research is to understand and improve the decision-making process of these women by creating a computerized childbirth decision aid. Such decision aids provide value when the decision is complex, when the outcome is uncertain, and when people vary in how they prioritize preferences; childbirth decisions for women with a prior cesarean meet all these criteria.
No study to date quantifies how women weigh the complexities of various considerations-medical and otherwise-in the delivery decision. The proposed research is significant, therefore, in that it will provide a much-needed method to help women prioritize and weigh their preferences related to childbirth decisions. More broadly, it responds to the recent NIH and AHRQ initiatives to promote the development of computerized decision aids to improve the quality of medical decisions.
A new investigator will lead a well-qualified, multi-disciplined team that has expertise in decision analysis, obstetric medicine, and research methodology in pursuit of the following specific aims:
- To validate a precise method to measure childbirth preferences. During the initial phase of this study, we will verify the accuracy of the Preferences Assessment Computer Module, measure internal consistency and assess content validity in a cross-sectional study.
- To test whether women who use the Preferences Assessment Computer Module will have increased clarity about their preferences-and about the implication of those preferences-in comparison to women in a control group. We will conduct a randomized controlled trial of pregnant women with a prior cesarean.
This Preferences Assessment Computer Module is appropriate to address not only VBAC decisions, but also decisions related to elective cesareans and induction. In short, the proposed research will advance the field by improving the quality of the decision-making process for childbirth.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Oregon
-
Portland, Oregon, United States, 97239
- Oregon Health & Science University Clinics
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- age 18 or older
- pregnant
- candidate for VBAC
- singleton pregnancy
- one prior cesarean
- with a non-vertical uterine scar
- English or Spanish speaking
Exclusion Criteria:
- more than one prior cesarean
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: Module 1 Only
|
|
Experimental: Modules 1, 2, and 3
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
---|
Decisional conflict scores (knowledge of options; clarity about preferences; decisional certainty; conflict) after using decision aid.
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Karen B Eden, PhD, Oregon Health and Science University
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 1R03HS013959-01A1 (U.S. AHRQ Grant/Contract)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pregnancy
-
Far Eastern Memorial HospitalCompletedCornual PregnancyTaiwan
-
Peking Union Medical College HospitalPeking Union Medical CollegeUnknownPregnancy | Pregnancy Related | Infant | Pregnancy Disease | Risk FactorChina
-
Ufuk UniversityNot yet recruitingPregnancy Complications | Pregnancy Loss | Pregnancy Preterm
-
Hadassah Medical OrganizationCompleted
-
Centre Hospitalier Universitaire de Saint EtienneCompletedProlonged PregnancyFrance
-
University Hospital, ToursCompleted
-
Technische Universität DresdenWithdrawnPregnancy Trimester, Second | Pregnancy Trimester, First | Pregnancy Trimester, ThirdGermany
-
Universitair Ziekenhuis BrusselMerck Serono International SAUnknownPregnancy | Pregnancy LossBelgium
-
Turku University HospitalUniversity of TurkuCompleted
-
Centre Hospitalier René DubosCompletedDeciduitis; Complicating Pregnancy
Clinical Trials on Use of Computerized Decision Aid on Childbirth
-
University of California, San FranciscoNational Cancer Institute (NCI)CompletedSurgical Procedure, UnspecifiedUnited States
-
University of Alabama at BirminghamPatient-Centered Outcomes Research InstituteActive, not recruitingSystemic Lupus ErythematosusUnited States
-
EPI-QCompleted
-
Brigham and Women's HospitalBayerActive, not recruitingChronic Thromboembolic Pulmonary HypertensionUnited States
-
Children's Hospital Medical Center, CincinnatiCompletedAutism Spectrum Disorder | Autistic Disorder | Child Development Disorders, Pervasive | Autism | Asperger Syndrome | Pervasive Developmental DisorderUnited States
-
Emory UniversityTerminated
-
University of Alabama at BirminghamPatient-Centered Outcomes Research InstituteCompletedSystemic Lupus ErythematosusUnited States
-
Erasme University HospitalAPHPWithdrawnGoal Directed Fluid TherapyFrance
-
Massachusetts General HospitalNational Cancer Institute (NCI); Boston Medical CenterCompletedGenetic TestingUnited States
-
VA Office of Research and DevelopmentCompleted